Kai-Thomas Schneider

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations

Federico Bertoglio, Viola Fühner, Maximilian Ruschig et al. · Cell Reports · 2021 · 107 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface

Federico Bertoglio, Doris Meier, Nora Langreder et al. · Nature Communications · 2021 · 102 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Shelf-Life Extension of Fc-Fused Single Chain Fragment Variable Antibodies by Lyophilization

Kai-Thomas Schneider, Toni Kirmann, Esther Veronika Wenzel et al. · Frontiers in Cellular and Infection Microbiology · 2021 · 38 citations · Full text

Pharmacy, Biotechnology, Immunology +14

Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment

Marcel Jaron, Michael Lehky, M Zara et al. · Viruses · 2022 · 24 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface

Federico Bertoglio, Doris Meier, Nora Langreder et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 18 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15